Educational information, not medical advice — ask your doctor or midwife.
Pingüica is the dried leaf and fruit of Arctostaphylos pungens, a shrub of the Mexican highlands. It is also called Mexican manzanita. In folk use it was taken as a tea for urinary and kidney complaints.
The plant is a close cousin of uva-ursi, also known as bearberry. Both hold arbutin, a compound the body turns into hydroquinone. That shared chemistry drives both the claims made for pingüica and the limits placed on it.
Here is the honest verdict. Human evidence for pingüica is very thin, and no use is proven. Long standing in Mexican tradition is not proof that it works, and it is not proof that it is safe.
Pingüica is not a mild kitchen herb. Products made from arbutin plants are usually held to short courses, and some people are told to skip them for good. Those limits are set out further down the page.
Most claims rest on arbutin. The body breaks arbutin down to hydroquinone, which leaves in the urine. In test tubes, hydroquinone slows some bacteria linked to bladder infections.
Whether enough reaches the bladder to help a real infection is not settled. Older work suggests the urine may need to be less acidic for any effect. No good trial in people has tested pingüica itself.
Animal work hints at other actions. Extracts have lowered blood sugar in diabetic rats. Rodent studies also report more urine flow, the effect of a diuretic (water pill).
The tannins in the leaf are astringent, meaning they tighten tissue and taste dry. In lab work tannins bind protein and slow some microbes. None of this has been shown to treat a disease in people.
Pingüica is sold mostly as loose dried leaf for tea. Mexican markets, herbal stalls and online shops are the usual sources.
Common forms include:
- Dried leaves and twigs for brewing. - Dried fruit, eaten or made into a drink. - Capsules or tablets of powdered leaf.
You may also see:
- Liquid extracts and tinctures made with alcohol. - Blended "kidney" or diuretic (water pill) tea mixes. - Syrups sold for cough.
Labelling is often poor. Arbutin content is almost never stated, so strength is hard to judge. Blends may also carry other herbs you did not plan to take.
The fruit and the leaf are not the same thing. Most of the arbutin sits in the leaf. A tea made from leaf is stronger than fruit eaten as food.
Pingüica has deep roots in Mexican folk medicine. Healers gave the leaf tea for burning urine, bladder trouble and kidney stones.
The fruit was eaten fresh and brewed into drinks in rural areas. Some communities also used the plant for coughs and for diabetes. It appears in regional herbal records and market surveys over many years.
Related Arctostaphylos plants were used in much the same way in North America and Europe. Bearberry leaf has a long record there for urinary complaints. That shared history shaped how pingüica is sold today.
These are records of what people did, not findings from trials. Past use tells you the plant was trusted. It does not tell you what it does in the body.
Stop taking it and see a doctor if you get:
- Fever, chills or pain in your back or side. - Blood in your urine. - Vomiting or severe stomach pain.
Get urgent care the same day if you notice:
- Yellow skin or eyes. - Confusion, fainting or a seizure. - A swollen face, lips or throat, or trouble breathing.
Also see your doctor if urinary symptoms have not improved within two or three days. A delay in treating an infection is the bigger danger here.
In Mexico pingüica is sold freely as a herbal remedy and as a wild food. In the United States it is sold as a dietary supplement, and it is not approved to treat any disease. In the European Union the related uva-ursi leaf is regulated as a traditional herbal medicine with strict limits on how long it may be used; pingüica itself is not an approved medicine there.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.